Centessa Pharmaceuticals plc financial data

Symbol
CNTA on Nasdaq
Location
Altrincham, Cheshire, United Kingdom
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 05 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1058% % -17%
Debt-to-equity 43% % 15%
Return On Equity -68% % -30%
Return On Assets -47% % -25%
Operating Margin -1425% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 134,447,836 shares 18%
Common Stock, Shares, Outstanding 134,421,149 shares 2.1%
Entity Public Float $621,502,000 USD 100%
Common Stock, Value, Issued $364,000 USD 2%
Weighted Average Number of Shares Outstanding, Basic 134,163,492 shares 15%
Weighted Average Number of Shares Outstanding, Diluted 134,163,492 shares 15%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $15,000,000 USD
General and Administrative Expense $50,179,000 USD 1.5%
Operating Income (Loss) $213,800,000 USD -32%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $239,307,000 USD -51%
Income Tax Expense (Benefit) $3,391,000 USD 15%
Net Income (Loss) Attributable to Parent $242,698,000 USD -50%
Earnings Per Share, Basic -1 USD/shares -24%
Earnings Per Share, Diluted -1 USD/shares -24%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $50,811,000 USD -87%
Other Assets, Current $2,759,000 USD 3.2%
Assets, Current $307,675,000 USD -46%
Deferred Income Tax Assets, Net $25,022,000 USD -7.5%
Property, Plant and Equipment, Net $894,000 USD 8.9%
Operating Lease, Right-of-Use Asset $10,295,000 USD -8.4%
Other Assets, Noncurrent $1,589,000 USD -29%
Assets $448,300,000 USD -26%
Accounts Payable, Current $8,683,000 USD 17%
Employee-related Liabilities, Current $5,949,000 USD -3.4%
Accrued Liabilities, Current $20,439,000 USD 7.8%
Liabilities, Current $29,122,000 USD 10%
Operating Lease, Liability, Noncurrent $7,759,000 USD -8.1%
Other Liabilities, Noncurrent $29,000 USD 0%
Liabilities $146,726,000 USD 33%
Accumulated Other Comprehensive Income (Loss), Net of Tax $2,600,000 USD 24%
Retained Earnings (Accumulated Deficit) $1,120,071,000 USD -28%
Stockholders' Equity Attributable to Parent $301,574,000 USD -40%
Liabilities and Equity $448,300,000 USD -26%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $57,246,000 USD -54%
Net Cash Provided by (Used in) Financing Activities $3,086,000 USD -71%
Net Cash Provided by (Used in) Investing Activities $222,388,000 USD -1427%
Common Stock, Shares Authorized 222,480,776 shares 21%
Common Stock, Shares, Issued 134,421,149 shares 2.1%
Common Stock, Par or Stated Value Per Share 0 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $278,065,000 USD -2734%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $50,811,000 USD -87%
Interest Paid, Excluding Capitalized Interest, Operating Activities $1,681,000 USD -34%
Deferred Tax Assets, Valuation Allowance $94,894,000 USD 30%
Deferred Tax Assets, Gross $124,181,000 USD 18%
Operating Lease, Liability $8,443,000 USD -6.4%
Depreciation $86,000 USD 132%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $242,193,000 USD -51%
Lessee, Operating Lease, Liability, to be Paid $12,799,000 USD -11%
Property, Plant and Equipment, Gross $1,906,000 USD 24%
Operating Lease, Liability, Current $684,000 USD 19%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,700,000 USD 2%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,667,000 USD 2%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Deferred Income Tax Expense (Benefit) $995,000 USD 129%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $4,356,000 USD -19%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,734,000 USD 2%
Deferred Tax Assets, Operating Loss Carryforwards $96,444,000 USD 25%
Unrecognized Tax Benefits $2,614,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,769,000 USD 2%
Operating Lease, Payments $408,000 USD 2%
Additional Paid in Capital $1,418,681,000 USD 3.2%
Depreciation, Depletion and Amortization $217,000 USD -9.6%
Deferred Tax Assets, Net of Valuation Allowance $29,287,000 USD -9.5%
Share-based Payment Arrangement, Expense $31,354,000 USD -4%
Interest Expense $10,090,000 USD 24%